Atropine Sulfate
NDC Package 0548-3339-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Atropine Sulfate is a medication used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). Marketed by Amphastar Pharmaceuticals, Inc., this product is identified by NDC 0548-3339.

Identification & Billing

NDC Package Code
0548-3339-00
Package Description
10 SYRINGE in 1 PACKAGE / 10 mL in 1 SYRINGE
Product Code
11-Digit Billing Format
00548333900
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Atropine Sulfate
Dosage Form
-
Usage Information
This medication is used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.

Regulatory & Marketing

Labeler Name
Amphastar Pharmaceuticals, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-02-1990
End Marketing Date
01-19-2013
Listing Expiration
01-19-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0548-3339-00 identifies a specific commercial package of 10 syringe in 1 package / 10 ml in 1 syringe of Atropine Sulfate, labeled by Amphastar Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Amphastar Pharmaceuticals, Inc. on January 02, 1990. The current certification is valid through January 19, 2013.

What are the primary indications for this medication?

This medication is used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.

How is this Amphastar Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00548333900. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0548-3339-00
11-Digit CMS (5-4-2)
00548-3339-00

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.